|
| |
IDE
Gene Information from Publications |
| Publication Link |
Summary of findings |
| 16914266 |
Observational study of gene-disease association. (HuGE Navigator) |
| 17192785 |
Meta-analysis of gene-disease association. (HuGE Navigator) |
| 17293876 |
Observational study and genome-wide association study of gene-disease association. (HuGE Navigator) |
| 17463249 |
Observational study and genome-wide association study of gene-disease association. (HuGE Navigator) |
| 17496198 |
Observational study of gene-disease association. (HuGE Navigator) |
| 17579348 |
Observational study of gene-disease association. (HuGE Navigator) |
| 17804762 |
Observational study of gene-disease association. (HuGE Navigator) |
| 17827400 |
Observational study of gene-disease association. (HuGE Navigator) |
| 17913278 |
Meta-analysis of gene-disease association. (HuGE Navigator) |
| 17953957 |
Observational study of gene-disease association. (HuGE Navigator) | →View more information from publications. |
Recent Publications on IDE: |  |
Interface wavelike deposits after descemet stripping automated endothelial keratoplasty.
To the Editor We greatly appreciated the recent article by Orina and... | 3rd November, 2009
| Institute of Vision and Optics, Department of Ophthalmology, University of
| Arch Ophthalmol. 2009 Oct;127(10):1389-90.
DOI Direct Link |
Combined risk effects of IDE and NEP gene variants on Alzheimer disease.
Polymorphisms in genes encoding amyloid beta-peptide (A beta)-degrading... | 30th October, 2009
| Department of Neurology, Kuopio University and University Hospital, PO Box
| J Neurol Neurosurg Psychiatry. 2009 Nov;80(11):1268-70.
DOI Direct Link |
Insulin degrading enzyme binds to the nonglycosylated precursor of varicella zoster virus gE protein found in the endoplasmic reticulum.
Insulin degradation enzyme (IDE) is a 110 kDa zinc-metalloprotease found... | 30th October, 2009
| Children's Hospital, University of Iowa, Iowa City, IA; Gade Institute,
| J Virol. 2009 Oct 28.
DOI Direct Link |
PPARG, KCNJ11, CDKAL1, CDKN2A-CDKN2B, IDE-KIF11-HHEX, IGF2BP2 and SLC30A8 are associated with type 2 diabetes in a Chinese population.
BACKGROUND: Recent advance in genetic studies added the confirmed... | 29th October, 2009
| Department of Endocrinology and Metabolism, Shanghai Jiao Tong University
| PLoS One. 2009 Oct 28;4(10):e7643.
DOI Direct Link |
The early elevation of interleukin 6 concentration in cerebrospinal fluid and delayed encephalopathy of carbon monoxide poisoning.
OBJECTIVE: This study was designed to investigate whether interleukin 6... | 28th October, 2009
| Department of Neurology, Kitasato University School of Medicine,
| Am J Emerg Med. 2009 Oct;27(8):992-6.
DOI Direct Link |
→View more research publications. |
Press Releases on IDE:
|
 |
| Impliant Announces the Addition of Vice President of Clinical and Regulatory Affairs to Executive Management Team |
19th November, 2009 |
Impliant, Inc. |
PRINCETON, N.J., Nov. 19 /PRNewswire/ -- Impliant, Inc., a developer of novel motion-sparing alternatives to traditional spinal fusion surgery, announced today that it has added Noel Rolon to
|
| Results Presented from First Study Reviewing Convergent Approach to Treating Atrial Fibrillation at American Heart Association Scientific Sessions |
19th November, 2009 |
nContact Surgical, Inc. |
MORRISVILLE, N.C., Nov. 19 /PRNewswire/ -- nContact Surgical, Inc. ("nContact"), a leader in the investigation of devices for minimally-invasive treatment for heart conditions,
|
| Endologix Receives IDE Approval for Fully Percutaneous Approach to EVAR |
18th November, 2009 |
Endologix, Inc. |
IRVINE, Calif., Nov. 18 /PRNewswire-FirstCall/ -- Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, announced today that it has received
|
| Cardiogenesis Reports Third Quarter 2009 Results |
10th November, 2009 |
Cardiogenesis Corporation |
IRVINE, Calif., Nov. 10 /PRNewswire-FirstCall/ -- Cardiogenesis Corporation (Pink Sheets: CGCP), a leading developer of surgical products used in the treatment of patients suffering
|
| Facet Solutions Enrolls 100th Patient in US Pivotal IDE Study |
9th November, 2009 |
Facet Solutions, Inc. |
HOPKINTON, Mass., Nov. 9 /PRNewswire/ -- Facet Solutions, Inc. today announced that it has enrolled the 100th patient in its randomized, controlled ACADIA(TM) IDE study for lumbar spinal
|
IDE results (if any) from reagent suppliers | 
|
Search Bioportfolio and other Life Science Sites for IDE,
or search for IDE on BioPortfolio's antibody search engine.
This page has been viewed 341 times
Recent Search Terms used to find this page: recent publications silverhawk plaque excision 2009 | Structure Function and Regulation of Insulin-Degrading Enzyme | Structure function and regulation of insulin-degrading enzyme | insulin degrading enzyme clinical trial | insulysin cancer | us patent 7498328 | Chapter 22 Structure Function and Regulation of Insulin-Degrading Enzyme | Structure function and regulation of insulin-degrading enzyme. | spectrum ide interface | .
Resources from the NCBI used on this page, NCBI's standard disclaimer applies.
|
